Antibiotic resistance of uropathogens isolated from Al-shifa hospital in Gaza Strip in 2002

Journal of Chemotherapy

Volumn 18, Issue 3, 2006, Pages 298-302

  Elmanama, Abdelraouf A ^a,c   Elaiwa, N M ^b   El Ottol, A E Y ^b   Abu Elamreen, F H ^b  

^a ISLAMIC UNIVERSITY OF GAZA   (Palestine)

^b AlShifa Hospital   (Palestine)

^c Islamic University Gaza   (Palestine)

Author keywords

Antimicrobial resistance; Gaza; Urinary tract infection; UTI

Indexed keywords

AMIKACIN; AMOXICILLIN; ANTIINFECTIVE AGENT; CEFACLOR; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; NALIDIXIC ACID; PIPERACILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; CONTROLLED STUDY; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; HEALTH SURVEY; KLEBSIELLA; NONHUMAN; PROTEUS; PSEUDOMONAS; REVIEW; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 33746185644     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.3.298     Document Type: Review

References (30)

1. Sader HS, Gales AC, Pfaller MA, et al. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program. Braz J Infect Dis, 2001;5, 4:200-214.
2. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrob Chemother 2003;51:69-76.
3. Matute AJ, Hak E, Schurink CA, et al. Resistance of uropathogens in symptomatic urinary tract infections in Leon, Nicaragua. Int J Antimicrob Agents. 2004;23(5):506-9.
4. Haller M, Brandis M, Berner R. Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy. Pediatr Nephrol. 2004;19(9):982-6. Epub 2004 Jun 18.
5. Turnidge J, Bell J, Biedenbach DJ, Jones RN. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int J Antimicrob Agents. 2002;20(1):10-7.
6. Mathai D, Jones RN, Pfaller MA. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Diagn Microbiol Infect Dis. 2001;40(3):129-36.
7. Winstanley TG, Limb DI, Eggington R, Hancock F. A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project. J Antimicrob Chemother 1997;40:591-4.
8. Trienekens T, Stobberingh E, Beckers F, Knottnerus A. The antibiotic susceptibility patterns of uropathogens isolated from general practice patients in southern Netherlands. J Antimicrob Chemother. 1994;33:1064-6.
9. Gordon KA, Jones RN. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis. 2003;45(4):295-301.
10. Jones RN, Kugler KC, Pfaller MA, Winokur PL. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis. 1999;35():55-63.
11. Pape L, Gunzer F, Ziesing S, Pape A, Offner G, Ehrich JH. Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection. Klin Padiatr. 2004;216(2):83-6.
12. Semra K, Suheyla S, Cenk S, Horu G, Mehmet G, Beril O. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jpn J Infect Dis 2005; 58:159-161.
13. Lavanya SV, Jogalakshmi D. Asymptomatic bacteriuria in antenatal women Indian J Med Microbiol 2002;20:105-106.
14. WHO. Guidelines on Standard Operating Procedures for Microbiology, http:7/w3.whosea.org/microbio/
15. th ed. Diagnostic Microbiology., Mosby Year Book. USA 1994;
16. Saracli MA, Baysallar M, Gun H. Nosocomial uropathogens and their antibiotic susceptibilities in a Turkish Military Hospital: a prospective and microbiological study. Turk J Med Sci, 1999;29:165-168.
17. th Informational Supplement. Document M100-S11. NCCLS 2001: Wayne, Pa.
18. Obi CL, Tarupiwa A, Simango C. Scope of urinary pathogens isolated in the Public Health Bacteriology Laboratory, Harare: antibiotic susceptibility patterns of isolates and incidence of haemolytic bacteria. Cent Afr J Med. 1996; 42(8):244-9.
19. Comment in: Cent Afr J Med. 1997;43(1):26-7.
20. Astal Z, Elmanama A, Elkichaoui A, Sharif F. Antibiotic resistance of bacteria associated with community acquired urinary tract infections in the southern area of Gaza Strip. Egypt J Med Lab Sci 2001;10(2):23-31.
21. Gales AC, Jones RN, Gordon KA, et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J Antimicrob Chemother. 2000;45(3):295-303.
22. Fluit AC, Jones ME, Schmitz FJ, Acar J, Gupta R, Verhoef J. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997. Antonie Van Leeuwenhoek. 2000;77(2):147-52.
23. Raka L, Mulliqi-Osmani G, Berisha L, et al. Etiology and susceptibility of urinary tract isolates in Kosova. Int J Antimicrob Agents. 2004;23 Suppl 1:S2-5.
24. Khan SW, Ahmed A. Uropathogens and their susceptibility pattern: a retrospective analysis. J Pak Med Assoc. 2001;51(2):98-100.
25. Shao HF, Wang WP, Zhang XW, Li ZD. Distribution and resistance trends of pathogens from urinary tract infections and impact on management. Zhonghua Nan Ke Xue. 2003;(9):690-2, 696.
26. Iqbal J, Rahman M, Kabir MS, Rahman M. Increasing ciprofloxacin resistance among prevalent urinary tract isolates in Bangladesh. Jpn J Med Sci Biol. 1997;50(6):241-250.
27. Ena J, Lopez-Perezagua M, Martinez-Peinado C, Cia-Barrio M, Ruiz-Lopez I. Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinlones. Diagn Microbiol Infect Dis. 1988;30:103-107.
28. Kachroo B. Association between antibiotic resistance and the expression of Dr adhesin among uropathogenic Escherichia coli. Chemotherapy 2001;47(2):97-103.
29. Wang H, Dzink-Fox JL, Chen M. Levy SB. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother 2001;45 (5):1515-1521.
30. Raz R, Okev N, Kennes Y, Gilboa A, Lavi I., Bisharat N. Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in Northern Israel. Isr Med Assoc J 2000: 2.